Received Mar 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | 2 | — | IM / LA |
Provider ordered Abrysvo outside of administration window. Administering medical assistant inadvertently grabbed Beyfortus as Abrysvo was no longer available at the site. Beyfortus was administered to the patient. Provider contacted patient and informed her of the inadvertent administration. Patient reported no adverse side effects.
Beyfortus